Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (CVS)
NYSE:CVS
CVS Health (CVS) Stock Price & Analysis
11,847 Followers
CVS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$53.70 - $81.71
Previous Close$54.91
Volume2.11M
Average Volume (3M)10.92M
Market Cap
$69.45B
Enterprise Value$137.04B
Total Cash (Recent Filing)$11.46B
Total Debt (Recent Filing)$79.39B
Price to Earnings (P/E)9.6
Beta0.44
Next Earnings
Jul 31, 2024EPS Estimate
$1.83Last Dividend Ex-Date
Apr 19, 2024Dividend Yield4.63%
Share Statistics
EPS (TTM)5.69
Shares Outstanding1,255,372,972
10 Day Avg. Volume20,537,702
30 Day Avg. Volume10,924,422
Standard Deviation0.07
R-Squared0.17
Alpha0.00276
Financial Highlights & Ratios
Price to Book (P/B)-1.60
Price to Sales (P/S)0.75
Price to Cash Flow (P/CF)-6.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.42
Enterprise Value/Gross Profit0.97
Enterprise Value/Ebitda10.03
Forecast
1Y Price Target
$70.94Price Target Upside28.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
CVS Health News
PremiumMarket News
SPY ETF Update, 5/3/2024 
Bulls Say, Bears Say
Bulls Say
Financial StrategyCVS's effective biosimilar strategy, as seen with the success of Cordavis, indicates strong potential for growth in specialty areas.
Operational PerformanceSignificant margin improvements in Medicare Advantage are projected to substantially increase CVS's operating earnings.
Stock RatingAnalyst maintains a Buy rating, reflecting confidence in the stock's ability to navigate near-term challenges.
Bears Say
Earnings VisibilityReducing 2024-2026E adjusted EPS estimates following Q1:24 earnings due to low earnings visibility and utilization headwinds.
Guidance And Stock DowngradeAnalyst downgrades CVS from Outperform to Market Perform with a lower 12-month price target due to increased uncertainties.
Medicare Advantage CostsCosts in the Medicare Advantage business were significantly above expectations.
---
Ownership Overview
0.91% Insiders
28.87% Mutual Funds
25.66% Other Institutional Investors
44.56% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
The estimated number of people who visited one or more of the websites owned by CVS Health
Desktop Users
Mobile Users
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $53.70 and its highest was $81.71 in the past 12 months.
What is CVS Health Corp’s market cap?
Currently, no data Available
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Jul 31, 2024 which is in 83 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 01, 2024. The company reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.695 by -$0.385.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.67 which represents an annual dividend yield of 4.63%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is $1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,255,372,900 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $1.31 in its last earnings report, missing expectations of $1.695. Following the earnings report the stock price went down -16.837%.
Which hedge fund is a major shareholder of CVS Health Corp?
Among the largest hedge funds holding CVS Health Corp’s share is Dodge & Cox. It holds CVS Health Corp’s shares valued at 2B.
---
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$70.94 (28.24% Upside)
$70.94 (28.24% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 4.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Very Bullish
Bullish news 83%
Bearish news 17%
Bearish news 17%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.35%
12-Months-Change
Fundamentals
Return on Equity
10.07%
Trailing 12-Months
Asset Growth
4.35%
Trailing 12-Months
Company Description
CVS Health Corp
Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
---
CVS Company Deck
---
CVS Earnings Call
Q1 2024
0:00 / 0:00
---
CVS Revenue Breakdown
52.22% Health Services
32.64% Pharmacy & Consumer Wellness
29.53% Health Care Benefits
0.13% Corporate/ Other
---
CVS Stock 12 Month Forecast
Average Price Target
$70.94
▲(28.24% Upside)
Technical Analysis
Best Analysts Covering CVS
1 Year
1 Year Success Rate
15/28 ratings generated profit
1 Year Average Return
+4.08%
reiterated a buy rating 8 days ago
Copying John Ransom's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +4.08% per trade.
---